Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The molecular and cellular origin of human prostate cancer.

Packer JR, Maitland NJ.

Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1238-60. doi: 10.1016/j.bbamcr.2016.02.016. Epub 2016 Feb 26. Review.

2.

Prostate cancer stem cells: do they have a basal or luminal phenotype?

Maitland NJ, Frame FM, Polson ES, Lewis JL, Collins AT.

Horm Cancer. 2011 Feb;2(1):47-61. doi: 10.1007/s12672-010-0058-y.

PMID:
21761340
3.

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.

Liu X, Grogan TR, Hieronymus H, Hashimoto T, Mottahedeh J, Cheng D, Zhang L, Huang K, Stoyanova T, Park JW, Shkhyan RO, Nowroozizadeh B, Rettig MB, Sawyers CL, Elashoff D, Horvath S, Huang J, Witte ON, Goldstein AS.

Cell Rep. 2016 Dec 6;17(10):2596-2606. doi: 10.1016/j.celrep.2016.11.010.

4.

Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.

Germann M, Wetterwald A, Guzmán-Ramirez N, van der Pluijm G, Culig Z, Cecchini MG, Williams ED, Thalmann GN.

Stem Cells. 2012 Jun;30(6):1076-86. doi: 10.1002/stem.1087.

5.

Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.

Park JW, Lee JK, Phillips JW, Huang P, Cheng D, Huang J, Witte ON.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4482-7. doi: 10.1073/pnas.1603645113. Epub 2016 Apr 4.

6.

Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model.

Chang HH, Chen BY, Wu CY, Tsao ZJ, Chen YY, Chang CP, Yang CR, Lin DP.

J Biomed Sci. 2011 Jan 18;18:6. doi: 10.1186/1423-0127-18-6.

7.

New insights into prostate cancer stem cells.

Chen X, Rycaj K, Liu X, Tang DG.

Cell Cycle. 2013 Feb 15;12(4):579-86. doi: 10.4161/cc.23721. Epub 2013 Jan 31. Review.

8.

Prostate cancer stem cells: are they androgen-responsive?

Oldridge EE, Pellacani D, Collins AT, Maitland NJ.

Mol Cell Endocrinol. 2012 Sep 5;360(1-2):14-24. doi: 10.1016/j.mce.2011.07.008. Epub 2011 Jul 23. Review.

PMID:
21802490
9.
11.

Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model.

Abou-Kheir WG, Hynes PG, Martin PL, Pierce R, Kelly K.

Stem Cells. 2010 Dec;28(12):2129-40. doi: 10.1002/stem.538.

12.

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.

Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M, Golub TR, Hahn WC.

Cancer Res. 2004 Dec 15;64(24):8867-75.

13.

Cellular and molecular pathology of prostate cancer precursors.

Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der Kwast T, Montironi R, Sakr WA.

Scand J Urol Nephrol Suppl. 2000;(205):19-43. Review.

PMID:
11144897
14.

A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM.

Nature. 2009 Sep 24;461(7263):495-500. doi: 10.1038/nature08361. Epub 2009 Sep 9.

15.

Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.

Tokar EJ, Diwan BA, Waalkes MP.

Environ Health Perspect. 2010 Jan;118(1):108-15. doi: 10.1289/ehp.0901059.

16.

Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity.

Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, Shen MM.

Nat Cell Biol. 2013 Mar;15(3):274-83. doi: 10.1038/ncb2697. Epub 2013 Feb 24.

17.

Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.

Kasper S.

Urol Oncol. 2009 May-Jun;27(3):301-3. doi: 10.1016/j.urolonc.2008.12.012. Review.

19.

Different Growth Patterns of Canine Prostatic Carcinoma Suggests Different Models of Tumor-Initiating Cells.

Akter SH, Lean FZ, Lu J, Grieco V, Palmieri C.

Vet Pathol. 2015 Nov;52(6):1027-33. doi: 10.1177/0300985815574008. Epub 2015 Mar 9.

PMID:
25755134
20.

MARKERS OF THE PROSTATE BASAL LAYER CELLS ARE EFFECTIVE INDICATORS OF ITS MALIGNANT TRANSFORMATION.

Petrov NS, Voskresensky MA, Grosov RV, Korshak OV, Zaritsky AY, Vereschagina NA, Komyakov BK, Popov BV.

Tsitologiia. 2016;58(7):526-33. English, Russian.

PMID:
30198661

Supplemental Content

Support Center